Currently only approved for men and transgender women; future trials expected.
While the combination drug should only be used as a last resort, ob/gyns still need to be aware of its potential risk for pregnant and lactating patients.
First non-insulin drug for pediatric use approved in nearly 20 years.
Results of a recent survey suggest employee-based drug abuse is a concern for many healthcare providers, though they don’t believe it can happen in their facilities.
Zolgensma (onasemnogene abeparvovec-xioi) is an adeno-associated virus vector-based gene therapy
Update: now available from three manufacturers.
Xellia Pharmaceuticals will manufacture essential antibiotics for Civica Rx.
Finalized rule is a step toward increasing drug pricing transparency.
New drug combines dapagliflozin, saxagliptin, and metformin.
First vaccine approved for all four Dengue virus serotypes in children and teens ages 9 through 16, but comes with major restrictions and controversy.